iifl-logo

Unichem Laboratories Ltd Quarterly Results

590.8
(-0.35%)
Jun 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Mar-2025Dec-2024Sept-2024Jun-2024Mar-2024

Gross Sales

587.18

533.09

507.36

446.43

431.7

Excise Duty

0

0

0

0

0

Net Sales

587.18

533.09

507.36

446.43

431.7

Other Operating Income

0

0

0

0

0

Other Income

9.25

13.62

8.69

3.86

6.15

Total Income

596.43

546.71

516.05

450.29

437.85

Total Expenditure

503.48

447.57

451.87

402.94

531.97

PBIDT

92.95

99.14

64.18

47.36

-94.12

Interest

5.46

6.75

4.79

4.03

4.59

PBDT

87.49

92.39

59.39

43.33

-98.71

Depreciation

29.69

30.54

32.26

28.33

27.16

Minority Interest Before NP

0

0

0

0

0

Tax

6.4

10.45

0.01

1.42

3.31

Deferred Tax

-1.57

-6.45

2.49

4.33

0.13

Reported Profit After Tax

52.97

57.85

24.63

9.26

-129.31

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

52.97

57.85

24.63

9.26

-129.31

Extra-ordinary Items

0

0

0

0

-122.19

Adjusted Profit After Extra-ordinary item

52.97

57.85

24.63

9.26

-7.12

EPS (Unit Curr.)

7.52

8.22

3.5

1.31

-18.37

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

14.08

14.08

14.08

14.08

14.08

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

15.82

18.59

12.64

10.6

-21.8

PBDTM(%)

14.9

17.33

11.7

9.7

-22.86

PATM(%)

9.02

10.85

4.85

2.07

-29.95

Unichem Labs.: Related NEWS

Unichem Labs Q3 Profit Drops 20.5% YoY, Revenue Up 14.5%
6 Feb 2025|10:48 PM

Revenue increased by 14.5% to ₹533 crore from ₹466 crore the previous year.

Read More
Unichem Labs plans to consolidate US generic formulations bizz
23 Sep 2024|03:02 PM

Bayshore Pharmaceuticals is a 100% subsidiary of Unichem Laboratories' parent firm, Ipca Laboratories Ltd.

Read More
Unichem Labs Goa facility gets 5 observations from USFDA
16 Jul 2024|11:11 AM

According to the corporation, the observations have no influence on business continuity or supplies to the US market.

Read More
Top 10 stocks for today - 16th July, 2024
16 Jul 2024|08:47 AM

Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.